First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer
Clinical trial NCT05141149 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05141149
- Sponsor
- Prestige Biopharma Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-05
- Primary completion
- 2026-07-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.